Literature DB >> 20351306

Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool.

Tina Shahani1, Renaud Lavend'homme, Aernout Luttun, Jean-Marie Saint-Remy, Kathelijne Peerlinck, Marc Jacquemin.   

Abstract

Although the liver is known to be the main site of factor VIII (FVIII) production, other organs are probably also important for the regulation of FVIII secretion. However, the study of the regulation of extrahepatic FVIII production has been hampered by the lack of definitive identification of human tissues able to secrete FVIII. Recent studies have shown that lung endothelial cells can synthesize FVIII. We therefore studied the production of FVIII by endothelial cells purified from other vascular beds. Because physiologic stress results in a rapid elevation of FVIII, we also investigated whether endothelial cells can store FVIII and secrete it after treatment with agonists. Microvascular endothelial cells from lung, heart, intestine, and skin as well as endothelial cells from pulmonary artery constitutively secreted FVIII and released it after treatment with phorbol-myristate acetate and epinephrine. By contrast, endothelial cells from the aorta, umbilical artery and umbilical vein did not constitutively secrete FVIII or release it after treatment with agonists, probably because of a lack of FVIII synthesis. Extrahepatic endothelial cells from certain vascular beds therefore appear to be an important FVIII production and storage site with the potential to regulate FVIII secretion in chronic and acute conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351306     DOI: 10.1182/blood-2009-07-232546

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A.

Authors:  Melanie Rose; Kewa Gao; Elizabeth Cortez-Toledo; Emmanuel Agu; Alicia A Hyllen; Kelsey Conroy; Guangjin Pan; Jan A Nolta; Aijun Wang; Ping Zhou
Journal:  Stem Cells Transl Med       Date:  2020-03-12       Impact factor: 6.940

Review 2.  Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Thromb Res       Date:  2012-03-14       Impact factor: 3.944

3.  Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.

Authors:  Alison Michels; Laura L Swystun; Jeffrey Mewburn; Silvia Albánez; David Lillicrap
Journal:  J Vis Exp       Date:  2017-08-14       Impact factor: 1.355

4.  Alternative strategies for gene therapy of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

5.  Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs.

Authors:  Chul-Yong Park; Jungeun Kim; Jiyeon Kweon; Jeong Sang Son; Jae Souk Lee; Jeong-Eun Yoo; Sung-Rae Cho; Jong-Hoon Kim; Jin-Soo Kim; Dong-Wook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

Review 6.  Platelets as delivery systems for disease treatments.

Authors:  Qizhen Shi; Robert R Montgomery
Journal:  Adv Drug Deliv Rev       Date:  2010-07-07       Impact factor: 15.470

7.  Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PI3-kinase and ERK1/2 pathways.

Authors:  Aftab Ahmad; Jerome B Schaack; Carl W White; Shama Ahmad
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

8.  Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

9.  Mesenchymal stem cells contribute to endogenous FVIII:c production.

Authors:  Chad Sanada; Chung-Jung Kuo; Evan J Colletti; Melisa Soland; Saloomeh Mokhtari; Mary Ann Knovich; John Owen; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

10.  The in vitro effects of sodium salicylate on von Willebrand factor and C-reactive protein production by endothelial cells.

Authors:  Minoo Shahidi; Mahmood Barati; Parisa Hayat; Behnaz Tavasoli; Masoomeh Bakhshayesh
Journal:  Inflammopharmacology       Date:  2014-07-24       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.